LKC Technologies

11/21/2025

When a patient’s OCT showed severe damage but his vision remained strong, Dr. Josué Lozano turned to the RETeval handheld ERG for clarity. This objective, non-invasive test confirmed stable ganglion cell function, helping guide his follow-up care. Learn more in his case study: 💻 (link in comments)

11/20/2025

How can objective, functional data from the RET𝘦𝘷𝘢𝘭 impact your disease management? Learn more in this case presentation from Dr. Paul Chous, where the RET𝘦𝘷𝘢𝘭 helped him answer the question: 𝐬𝐡𝐨𝐮𝐥𝐝 𝐈 𝐫𝐞𝐟𝐞𝐫 𝐭𝐡𝐢𝐬 𝐩𝐚𝐭𝐢𝐞𝐧𝐭?

11/19/2025

Traditional electrophysiology testing can be challenging, especially for our youngest patients. Dr. Ayelén Ginesta shares how the RET𝘦𝘷𝘢𝘭 handheld device makes ERG testing portable, non-invasive, and practical for every patient.

11/18/2025

The American Academy of Ophthalmology now includes ERG in their Preferred Practice Pattern for diabetic retinopathy. RET𝘦𝘷𝘢𝘭 is making it easy for thousands of clinicians to follow that guidance. This handheld ERG delivers fast, functional insights that traditional tools can’t provide. No dilation, no corneal contact - 𝐣𝐮𝐬𝐭 𝐨𝐛𝐣𝐞𝐜𝐭𝐢𝐯𝐞 𝐝𝐚𝐭𝐚 𝐭𝐡𝐚𝐭 𝐡𝐞𝐥𝐩𝐬 𝐲𝐨𝐮 𝐬𝐭𝐚𝐲 𝐚𝐡𝐞𝐚𝐝 𝐨𝐟 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐚𝐧𝐝 𝐥𝐞𝐚𝐝 𝐰𝐢𝐭𝐡 𝐜𝐨𝐧𝐟𝐢𝐝𝐞𝐧𝐜𝐞.

11/14/2025

Diabetic retinopathy, the most common of the diabetic eye diseases, is the leading cause of blindness for adults between the ages of 20 and 74. According to the National Eye Institute, early intervention for DR can 𝐫𝐞𝐝𝐮𝐜𝐞 𝐫𝐢𝐬𝐤 𝐨𝐟 𝐛𝐥𝐢𝐧𝐝𝐧𝐞𝐬𝐬 𝐛𝐲 95%. As we recognize World Diabetes Day, we're celebrating all that eye care providers do to protect their patients - from closely managing follow-ups, implementing functional testing, improving patient education, and beyond. ✅

11/13/2025

What’s as revolutionary as the smartphone? Prof. Yetik says it’s the RET𝘦𝘷𝘢𝘭 handheld ERG.

11/12/2025

𝐂𝐨𝐮𝐥𝐝 𝐚 𝐬𝐢𝐧𝐠𝐥𝐞 𝐧𝐮𝐦𝐛𝐞𝐫 𝐡𝐞𝐥𝐩 𝐩𝐫𝐞𝐝𝐢𝐜𝐭 𝐯𝐢𝐬𝐢𝐨𝐧-𝐭𝐡𝐫𝐞𝐚𝐭𝐞𝐧𝐢𝐧𝐠 𝐝𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐫𝐞𝐭𝐢𝐧𝐨𝐩𝐚𝐭𝐡𝐲? New research from 𝘖𝘱𝘩𝘵𝘩𝘢𝘭𝘮𝘰𝘭𝘰𝘨𝘺 𝘚𝘤𝘪𝘦𝘯𝘤𝘦 finds the RET𝘦𝘷𝘢𝘭 DR Score outperformed other metrics in predicting progression to vision-threatening complications. For clinicians, this means gaining earlier insight into which patients may be at higher risk. Read more in this article from Healio with Dr. Jeff Gerson ⬇️

A single-number metric from a handheld device outperformed dozens of other measurements for the prediction of vision-threatening complications in diabetic retinopathy, according to data in Ophthalmology Science. The device, RetEval (LKC Technologies), measures electroretinography (ERG) and pupil res...

11/11/2025

Fast, reliable, and comfortable for patients. ERG testing with the RET𝘦𝘷𝘢𝘭 checks all the boxes. See how patient toleration compares across studies in both children and adults.

11/11/2025

Managing diabetic retinopathy means knowing which patients are most at risk – and acting before vision is lost. Drs. Nate Lighthizer, Chris Lopez, and Paul Chous share how the latest research on the RET𝘦𝘷𝘢𝘭 DR Score gives them the clarity and confidence to turn insights into informed, actionable care.

11/07/2025

Your patients deserve comfortable testing and results that can be easily explained to them. RET𝘦𝘷𝘢𝘭 helps you deliver both - quickly, easily, and confidently. 𝐘𝐨𝐮'𝐯𝐞 𝐧𝐞𝐯𝐞𝐫 𝐬𝐞𝐞𝐧 𝐄𝐑𝐆 𝐥𝐢𝐤𝐞 𝐭𝐡𝐢𝐬 𝐛𝐞𝐟𝐨𝐫𝐞!

11/06/2025

With the RET𝘦𝘷𝘢𝘭 device, Dr. Viviane Lanzelotte gains the insights she needs to make confident clinical decisions in pediatric care.

11/04/2025

𝐓𝐡𝐞𝐫𝐞'𝐬 𝐬𝐭𝐢𝐥𝐥 𝐭𝐢𝐦𝐞 𝐭𝐨 𝐫𝐞𝐠𝐢𝐬𝐭𝐞𝐫! Don't miss our 𝐟𝐫𝐞𝐞 𝐰𝐞𝐛𝐢𝐧𝐚𝐫 with Dr. Amithavikram Hathibelagal as he explores how ERG can become a practical part of your everyday ophthalmic care. He'll share real clinical cases, practical ERG applications, and ON/OFF interpretation insights to help you strengthen your understanding of retinal function to benefit your patients.